Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
586 participants
INTERVENTIONAL
2020-05-15
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical and Metabolic Characterization of Long-term Courses of Obesity Patients
NCT04375371
Pilot Project on Interdisciplinary Therapy of Obesity
NCT01344525
Access to Bariatric Surgery In Europe
NCT03105050
Addiction Remission and Addiction Transfer After Bariatric Surgery
NCT02757716
Post-Bariatric Weight Regain Behavioral Intervention
NCT03564392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the ACHT project is to ensure long-term therapeutic success after an operation. This is done through a digitally supported, structured, cross-sectoral and close-to-home aftercare program. Obesity case managers (obesity guides) coordinate the aftercare process and monitor the therapy goals. A digital case file links patients, case managers, resident doctors and obesity centers. Individual exercise goals, nutritional advice and psychological support are part of ACHT. ACHT is connected to quality assurance measures of a medical society.
Four groups are compared in the ACHT study. One group begins their 18 months ACHT aftercare program directly after the operation, another group 18 months after the operation. These two groups are compared to patients who receive standard care. Through these two intervention groups, we hope to examine the long-term effects of the program within the given time constraints of the study.
ACHT is funded for three and a half years by the Federal Joint Committee as part of the Innovation Fund with approx. 4.5 million euros.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early aftercare (intervention group 1)
Patients in this group will begin the ACHT program immediately after their bariatric metabolic operation. 3 weeks post surgery, they will attend the initial examination and meet their case manager. The obesity guide will then set up an electronic case file for the patient and introduce the patient to the obesity app. Through the next 18 months the obesity guide will monitor the patient's therapeutic success and adherence to the therapeutic goals. In month 2 patients visit a sports physician who assesses their mobility and physical capacity to compile a personal training plan, which will be uploaded onto the patient's case file and thus be available to the patient via the app. In months 3,6,9.12 and 18, patients will attend their aftercare appointments at specially trained ACHT physicians, where they will be physically examined by a physician and receive tailored dietary advice from a nutritional advisor. In month 18 patients revisit the surgical centre for the follow-up examination
early aftercare
This group begins the aftercare program immediately after their bariatric surgery.
Mid-term to long-term aftercare (intervention group 2)
Patients in this group first visit the study center 18 months after their bariatric surgery for the initial examination and start the program in month 19 post-op. At the center, they will meet their obesity guide who will set up an electronic case file for the patient and introduce the patient to the obesity app. Throughout the next 18 months, the obesity guide will monitor the patient's therapeutic success and adherence to the therapeutic goals. In month 19 post-surgery, patients visit a sports physician who assesses their mobility and devises a personal training plan. This plan will be uploaded onto the patient's case file and made available to the patient via the app. In months 19,21,24, 30 and 36, patients attend their aftercare appointments at specially trained ACHT physicians, where they will be physically examined and receive tailored dietary advice. In month 36, patients will be reexamined at the study center.
mid-term to late aftercare
This group begins the aftercare program 18 months post surgery.
control group 1 (early aftercare)
Analogous to intervention group I, patients in this group are invited to the study center after verbal and written information. These patients will attend the one-off evaluation examination (18 months after the operation) at the obesity centre.
If interested, patients in this group can be included in intervention group II until the required number of cases (140 patients) has been reached.
No interventions assigned to this group
control group 2 (mid-term to long-term aftercare)
Analogous to intervention group II, patients in this group are invited to the study center after verbal and written information. These patients will attend the one-off evaluation examination at the study center 36 months after the operation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
early aftercare
This group begins the aftercare program immediately after their bariatric surgery.
mid-term to late aftercare
This group begins the aftercare program 18 months post surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients who have already approved to have their data entered into the National Registry of metabolic and bariatric diseases (StuDoQ, DGAV)
* Sufficient knowledge of the German language to use the app, to communicate with the obesity case manager (obesity guide) and to fill out the questionnaires
* signed consent form
group specific criteria:
Intervention group I ("early aftercare"):
* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* Consent to participate in the selective contract
* The bariatric metabolic operation (sleeve gastrectomy, Roux-en-Y-gastric bypass) was carried out 3 weeks (+/- 10 days) before the entrance examination
* iOS or Android smartphone (operating system: iOS 11 or higher or Android 6 or higher) with internet access can be used for study
* Sufficient mobility to get to the aftercare practice regularly and to complete an exercise program
Intervention Group II ("medium-term and late after care") recruited from control group I:
* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* Consent to participate in the selective contract
* The bariatric-metabolic operation (sleeve gastrectomy or Roux-en-Y-gastric bypass) was carried out 18 months (+/- 2 months) before time of recruitment
Control group I (compared to early intervention):
* Insured with the Allgemeine Ortskrankenkasse (AOK) Bayern
* The bariatric metabolic operation was carried out 18 months (+/- 2 months) before time of recruitment
* Sufficient mobility (see intervention group, so that groups are comparable)
Control group II (compared to late intervention):
* The bariatric metabolic operation was carried out 36 months (+/- 2 months) before the recruitment date
* Sufficient mobility (see intervention group, so that groups are comparable)
* The health insurance is irrelevant in this group
Exclusion Criteria
* Planned two-stage surgical procedure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsche Stiftung für chronisch Kranke
UNKNOWN
Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie e.V. (DGAV)
UNKNOWN
AOK Bayern
INDUSTRY
Kassenärztliche Vereinigung Bayern
UNKNOWN
symeda GmbH
UNKNOWN
AMC Wolfartklinik Gräfelfing
UNKNOWN
Schön Klinik Nürnberg Fürth
UNKNOWN
Dr. Lubos Kliniken Bogenhausen
UNKNOWN
Klinikum Memmingen
UNKNOWN
Klinikum Passau
UNKNOWN
Klinikum Nürnberg
OTHER
Helmholtz Zentrum München
INDUSTRY
Wuerzburg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin Fassnacht
Prof. Dr. Martin Fassnacht (Head of Endocrinolgy)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bettina Zippel-Schultz, PhD
Role: STUDY_DIRECTOR
Deutsche Stiftung für chronisch Kranke
Martin Fassnacht, MD
Role: PRINCIPAL_INVESTIGATOR
Wuerzburg University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AMC WolfartKlinik, Zentrum für Adipositas- und Metabolische Chirurgie
Gräfelfing, , Germany
Adipositaszentrum Klinikum Memmingen
Memmingen, , Germany
Chirurgische Klinik München-Bogenhausen GmbH
München, , Germany
Klinikum Nürberg
Nuremberg, , Germany
Sana Klinikum Offenbach GmbH
Offenbach, , Germany
Klinikum Passau
Passau, , Germany
Wuerzburg University Hospital
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACHT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.